Countries Manufacturing Pharmaceuticals for the US Market: A 10-Year Analysis of Public Data

1. Eban, K. Bottle of Lies: The inside Story of the Generic Drug Boom. New York, NY: HarperCollins; 2019.
Google Scholar2. Gibson, R, Singh, JP. China Rx: Exposing the Risks of America’s Dependence on China for Medicine. Guilford, CT: Prometheus Books; 2018.
Google Scholar3. White, CM. Generic drugs not as safe as FDA wants you to believe. Ann Pharmacother. 2020;54(3):283-286. doi:10.1177/1060028019881692.
Google Scholar | SAGE Journals | ISI4. Eccleston-Turner, M. How countries get away with hoarding drugs in a pandemic. The Conversation. July 6, 2020. Accessed October 19, 2021. https://theconversation.com/how-countries-get-away-with-hoarding-drugs-in-a-pandemic-141854.
Google Scholar5. Kolchinsky, P. It’s time to bring generic drug manufacturing back to the U.S. STAT. June 2, 2020. Accessed October 19, 2021. https://www.statnews.com/2020/06/02/bring-manufacturing-generic-drugs-back-to-u-s/.
Google Scholar6. Palmer, E. Coronavirus spurs India to restrict exports of 2 dozen drugs. Fierce Pharma. March 3, 2020. Accessed October 19, 2021. https://www.fiercepharma.com/manufacturing/coronavirus-spurs-india-to-restrict-exports-two-dozen-drugs.
Google Scholar7. Swanson, A. Coronavirus spurs U.S. efforts to end China’s chokehold on drugs. The New York Times. March 22, 2020. Accessed October 19, 2021. https://www.nytimes.com/2020/03/11/business/economy/coronavirus-china-trump-drugs.html.
Google Scholar8. Kacik, A. Providers push for onshoring PPE, pharmaceutical production. Mod Healthc. 2020;50(25):18. Accessed October 21, 2021. https://www.modernhealthcare.com/supply-chain/providers-push-onshoring-ppe-pharmaceutical-production.
Google Scholar9. The White House . Building resilient supply chains, revitalizing American manufacturing, and fostering broad-based growth: 100-day reviews under Executive Order 14017. Washington, DC; June 2021. Accessed October 19, 2021. https://www.whitehouse.gov/wp-content/uploads/2021/06/100-day-supply-chain-review-report.pdf.
Google Scholar10. US Food and Drug Administration . Drug establishments current registration site. December 18; 2020. Accessed October 18, 2021. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-establishments-current-registration-site.
Google Scholar11. US Food and Drug Administration . Electronic Drug Registration and Listing System (eDRLS). November 4; 2021. Accessed November 22, 2021. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/electronic-drug-registration-and-listing-system-edrls.
Google Scholar12. US Food and Drug Administration . National drug code database background information. March 20; 2017. Accessed November 22, 2021. https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information.
Google Scholar13. US Food and Drug Administration . Approved drug products with therapeutic equivalence evaluations—Orange book. October 8; 2021. Accessed October 18, 2021. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book.
Google Scholar14. US Food and Drug Administration . Purple book database of licensed biological products. October 8; 2021. Accessed October 18, 2021. https://purplebooksearch.fda.gov/.
Google Scholar15. US National Institutes of Health, National Library of Medicine . DailyMed. Accessed October 18, 2021. https://dailymed.nlm.nih.gov/dailymed/spl-resources-all-drug-labels.cfm.
Google Scholar16. US Food and Drug Administration . Structured product labeling resources. Accessed October 18, 2021. https://www.fda.gov/industry/fda-resources-data-standards/structured-product-labeling-resources.
Google Scholar17. Stockman, F. Our drug supply is sick. How can we fix it? The New York Times. September 18, 2021. Accessed November 22, 2021. https://www.nytimes.com/2021/09/18/opinion/drug-market-prescription-generic.html.
Google Scholar18. Berndt, ER, Conti, RM, Murphy, SJ. The generic drug user fee amendments: an economic perspective. Working Paper no. 23642. National Bureau of Economic Research; August 2017. Accessed October 18, 2021. https://www.nber.org/papers/w23642.
Google Scholar19. Kaygisizi, NB, Shivdasani, Y, Conti, RM, Berndt, ER. The geography of prescription pharmaceuticals supplied to the U.S.: levels, trends and implications. Working Paper no. 26524; December 2019. Accessed October 18, 2021. http://www.nber.org/papers/w26524.
Google Scholar20. Shivdasani, Y, Kaygisiz, NB, Berndt, ER, Conti, RM. The geography of prescription pharmaceuticals supplied to the USA: levels, trends, and implications. J Law Biosci. 2021;8(1):lsaa085. doi:10.1093/jlb/lsaa085.
Google Scholar | Crossref | Medline21. US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality . Report on the state of pharmaceutical quality: fiscal year 2020: assuring quality medicines are available to the American public; August 2021. Accessed October 18, 2021. https://www.fda.gov/media/151561/download.
Google Scholar22. Hicks, CD. Taking action to topple the great wall around American pharmaceutical “trade secrets.” Fla Coastal L R. 2021;21. Accessed October 19, 2021. http://dx.doi.org/10.2139/ssrn.3842489.
Google Scholar | Crossref23. US Food and Drug Administration . Mutual recognition agreement / frequently asked questions and answers; January 2021. Accessed June 19, 2021. https://www.fda.gov/media/103391/download.
Google Scholar24. Eban, K, Salzman, S. In generic drug plants in China and India, data falsification is still a problem. STAT. October 29, 2019. Accessed October 19, 2021. https://www.statnews.com/2019/10/29/data-falsification-still-problematic-china-india-generic-drug-plants/.
Google Scholar25. Silverman, E. As quality concerns rise, FDA report shows Indian drug plants inspected more often—and had more problems. STAT. June 16, 2020. Accessed October 21, 2021. https://www.statnews.com/pharmalot/2020/06/16/as-quality-concerns-rise-fda-report-shows-indian-drug-plants-inspected-more-often-and-had-more-problems/.
Google Scholar26. US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality . Report on the state of pharmaceutical quality: fiscal year 2019: assuring quality medicines are available for the American public; February 2020. Accessed October 18, 2021. https://www.fda.gov/media/135046/download.
Google Scholar27. Flavin, B, Happe, LE, Hatton, RC. Meeting report: an exploration into the scientific and regulatory aspects of pharmaceutical drug quality in the United States [published online ahead of print December 31, 2021]. Expert Opin Drug Saf. doi:10.1080/14740338.2022.2020244.
Google Scholar | Crossref | Medline28. US Food and Drug Administration . Quality metrics for drug manufacturing. Accessed October 19, 2021. https://www.fda.gov/drugs/pharmaceutical-quality-resources/quality-metrics-drug-manufacturing.
Google Scholar29. Dabestani, A, Bazil, CW, Costantino, RC, et al. Evidence-based quality scores for rating drug products and their utility in health systems [published online ahead of print May 26, 2020]. medRxiv. doi:10.1101/2020.05.22.20110775.
Google Scholar | Crossref30. US Food and Drug Administration . Drug shortages: root causes and potential solutions; 2019. Accessed November 23, 2021. https://www.fda.gov/media/131130/download.
Google Scholar

留言 (0)

沒有登入
gif